Stock

Kiora Pharmaceuticals, Inc. KPRX

$2.49-5.32%

All stocks Create account to unlock

Overview

KPRX market data

Price History

KPRX price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for KPRX. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

2 captured

Kiora Pharmaceuticals Released Preclinical Data Showing That KIO-300 Significantly Suppressed Seizure-associated Electrophysiological Activity In An Ex Vivo Temporal Lobe Epilepsy Model · Jun 18, 2026, 11:10 AM

Kiora Pharmaceuticals Files Prospectus For Offering 11.797M Common Stock On Behalf Of Selling Shareholders · May 18, 2026, 8:40 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock